Regarding AKT, all studies presented here involving Genistein [255,256,257,258,259] and Delphinidin [212,260,261,262,263] treatment decreased AKT activation, highlighting that as a robust effect of these two flavonoids in different types of cancer. Here, AKT1 is linked to cancer.